By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Food and Drug Administration (FDA) 

5600 Fishers Lane

Rockville  Maryland  20857  U.S.A.
Phone: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332) Fax:

FDA Overview:

The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.

•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.

FDA's Mission Statement

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.

Key Statistics

Ownership: Private

Web Site: FDA


Company News
Aspire Bariatrics Submits To FDA A PMA Application Of AspireAssist, A Minimally-Invasive Alternative To Weight Loss Surgery 7/28/2015 11:33:01 AM
U.S. FDA Accepts For Review CSL Behring's Biologics License Application For Its Novel Rviii-Singlechain Therapy For Patients With Hemophilia A 7/28/2015 11:21:01 AM
Kerastem Receives Conditional Approval From FDA For Alopecia Trial 7/28/2015 11:17:26 AM
FDA Grants Breakthrough Therapy Designation To Eisai Inc. (ESALF.PK)'s Lenvatinib For The Potential Treatment Of Metastatic Renal Cell Carcinoma 7/28/2015 11:15:13 AM
Cytori Therapeutics, Inc. (CYTX) Licensee Kerastem Receives Conditional Approval From FDA For Alopecia Trial 7/28/2015 10:28:58 AM
FibroGen, Inc. (FGEN) Receives FDA Clearance to Proceed With Clinical Study of FG-3019 in Duchenne Muscular Dystrophy 7/28/2015 7:05:31 AM
ANI Pharma And Sofgen Pharmaceuticals Announce FDA Approval Of Nimodipine 30mg Capsules 7/27/2015 10:33:01 AM
TxCell Receives Fast Track Designation From FDA For Ovasave 7/27/2015 10:27:05 AM
Adapt Pharma Submits NDA To FDA For Narcan (Naloxone) Nasal Spray 7/27/2015 10:22:01 AM
MediciNova, Inc. Announces FDA Approval Of The Second Phase II Protocol For MN-001 In NASH Which Targets NASH Patients With Hypertriglyceridemia 7/27/2015 7:11:15 AM